4D Molecular Therapeutics Inc (FDMT) Stock is more thoughtful than you think
Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]
Growing at an Unbelievable Rate: 4D Molecular Therapeutics Inc (FDMT) Stock
Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]
Despite the lack of deep value, there is something else: 4D Molecular Therapeutics Inc (FDMT) Stock
Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]
Is 4D Molecular Therapeutics Inc (FDMT) Stock worth its current valuation?
Goldman raised the price target for the 4D Molecular Therapeutics Inc (NASDAQ:FDMT) stock to “a Buy”. The rating was released on February 07, 2024, according to finviz. The research report from Cantor Fitzgerald has initiated the stock to Overweight, with a price target set at $32. The stock was upgraded by Leerink Partners, who disclosed […]
